FRANCESCHINO, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 288
EU - Europa 169
AS - Asia 57
Totale 514
Nazione #
US - Stati Uniti d'America 283
DE - Germania 41
CN - Cina 28
SE - Svezia 27
IT - Italia 23
UA - Ucraina 22
IE - Irlanda 21
RU - Federazione Russa 16
SG - Singapore 15
GB - Regno Unito 6
HK - Hong Kong 6
CA - Canada 5
FI - Finlandia 5
TR - Turchia 3
BE - Belgio 2
BG - Bulgaria 2
FR - Francia 2
IN - India 2
NL - Olanda 2
AM - Armenia 1
IR - Iran 1
JP - Giappone 1
Totale 514
Città #
Woodbridge 40
Ann Arbor 33
Chandler 29
Jacksonville 24
Ashburn 21
Dublin 19
Fairfield 19
Frankfurt am Main 17
Dearborn 15
Houston 14
Göttingen 9
Nanjing 8
Princeton 8
Shanghai 7
Hong Kong 6
Milan 6
New York 6
Seattle 6
Singapore 5
Trinitapoli 5
Altamura 4
Cambridge 4
Lachine 4
Lawrence 4
Beijing 3
Boardman 3
Fürstenwalde 3
Hebei 3
Monmouth Junction 3
Norwalk 3
Wilmington 3
Brussels 2
Falls Church 2
Huizen 2
Jinan 2
Plovdiv 2
Shenyang 2
Changsha 1
Evanston 1
Foggia 1
Fremont 1
Helsinki 1
Kunming 1
Leawood 1
Levico Terme 1
London 1
Munich 1
New Delhi 1
Newark 1
Philadelphia 1
Pune 1
San Diego 1
San Mateo 1
Santa Clara 1
Shaoxing 1
Toronto 1
University Park 1
Washington 1
Yerevan 1
Zanjan 1
Totale 369
Nome #
Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib 154
Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease 131
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 128
Bim promoter is highly methylated in malignant lymphoid cell lines, leading to downregulation of Bim expression and protection from apoptosis 103
Totale 516
Categoria #
all - tutte 1.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 0 0 0 0 8 10 18 5 6 1 5 0
2020/202134 5 1 6 4 3 0 5 0 4 4 1 1
2021/202241 4 1 7 3 4 3 3 1 0 1 1 13
2022/202398 7 36 13 8 8 13 0 2 9 0 1 1
2023/202486 1 4 5 8 12 12 13 19 3 2 0 7
2024/202530 10 6 8 6 0 0 0 0 0 0 0 0
Totale 516